Elsevier

Advanced Drug Delivery Reviews

Volume 56, Issue 8, 29 April 2004, Pages 1067-1084
Advanced Drug Delivery Reviews

Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy

https://doi.org/10.1016/j.addr.2004.01.001Get rights and content

Section snippets

The folate receptor: its enigmatic role in physiology and its promise in therapeutics

The folate receptor (FR), also known as the folate binding protein (FBP or Folbp), is a glycopolypeptide with a high affinity (KD<10−9 M) for folic acid and the physiologic circulating form of the vitamin, N5-methyltetrahydrofolate [1]. Human FR is encoded by a family of genes whose homologous products are termed FR types -α, -β and -γ [2], [3], [4], [5], [6], [7]. A fourth isoform, named FR-δ has been tentatively identified from genome database mining, but neither its tissue expression nor its

The FR gene family: diversity that aids targeted therapies

The occurrence of multiple, functionally distinguishable, tissue-specific FR isoforms provides an added level of tissue selectivity in FR-mediated therapy/prognosis/diagnosis. The different ligand specificities of FR-α versus -β (discussed in Section 2.3) may be particularly beneficial in the design of folate-based low molecular weight drugs to selectively target FR-β-positive pathologic tissues avoiding nephrotoxicity due to drug uptake via FR-α expressed in proximal kidney tubules.

Mechanisms governing FR gene expression: opportunities to selectively modulate FR levels for more effective targeting

In recent years, a variety of transcriptional and post-transcriptional mechanisms have been identified as likely contributors to the unique tissue expression patterns of FR genes. Some of these mechanisms offer novel insights into gene regulation in general. From a clinical perspective, the concept of utilizing these regulatory mechanisms to obtain a selective overexpression of the receptor in malignant cells is proving to be a feasible approach to enhancing the efficacy of FR-targeted

Future prospects

The detailed tissue distribution patterns of FR isoforms in normal and pathologic tissues have been established by several groups using different methodologies. The results of those studies and the inherent properties of FR in these tissues have made the receptor a seemingly ideal marker/target, for therapeutic intervention. In recent years FR has been a paradigm for many novel experimental approaches in targeted therapeutics. Conceptual and technical innovations and refinements in the

Acknowledgements

We wish to thank Robert Trumbly, Ph.D. for carrying out the BLAST searches of the NCBI databases. This work was supported by NIH RO1 grants CA 80183 and CA 70873 to M.R.

First page preview

First page preview
Click to open first page preview

References (145)

  • Y Lu et al.

    Folate-mediated delivery of macromolecular anticancer therapeutic agents

    Adv. Drug Deliv. Rev.

    (2002)
  • J Sudimack et al.

    Targeted drug delivery via the folate receptor

    Adv. Drug Deliv. Rev.

    (2000)
  • S.F Atkinson et al.

    Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells

    J. Biol. Chem.

    (2001)
  • C.J Mathias et al.

    Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts

    Nucl. Med. Biol.

    (1999)
  • R.J Lee et al.

    Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis

    J. Biol. Chem.

    (1994)
  • Y Lu et al.

    Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects

    J. Control. Release

    (2003)
  • A.C Antony et al.

    Isolation and characterization of a folate receptor from human placenta

    J. Biol. Chem.

    (1981)
  • P.C Elwood et al.

    The isolation, characterization, and comparison of the membrane-associated and soluble folate-binding proteins from human KB cells

    J. Biol. Chem.

    (1986)
  • J Selhub et al.

    The folate-binding protein of rat kidney. Purification, properties, and cellular distribution

    J. Biol. Chem.

    (1984)
  • S.A Suleiman et al.

    Purification and characterization of a folate binding protein from porcine choroid plexus

    Arch. Biochem. Biophys.

    (1981)
  • A.C Antony et al.

    Isolation, characterization, and comparison of the solubilized particulate and soluble folate binding proteins from human milk

    J. Biol. Chem.

    (1982)
  • K.E Brigle et al.

    Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement

    J. Biol. Chem.

    (1991)
  • C.A Luhrs et al.

    A human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail

    J. Biol. Chem.

    (1989)
  • B.A Kamen et al.

    Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles

    J. Biol. Chem.

    (1988)
  • K.E Brigle et al.

    Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells

    Biochem. Pharmacol.

    (1994)
  • K.M Maziarz et al.

    Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta

    J. Biol. Chem.

    (1999)
  • A.C Antony et al.

    Identification of a Mg2+-dependent protease in human placenta which cleaves hydrophobic folate-binding proteins to hydrophilic forms

    J. Biol. Chem.

    (1989)
  • P.C Elwood et al.

    The conversion of the human membrane-associated folate binding protein (folate receptor) to the soluble folate binding protein by a membrane-associated metalloprotease

    J. Biol. Chem.

    (1991)
  • X.Y Yang et al.

    Isolation and characterization of a folate receptor-directed metalloprotease from human placenta

    J. Biol. Chem.

    (1996)
  • A.C Antony

    Folate receptors

    Annu. Rev. Nutr.

    (1996)
  • S.W Lacey et al.

    Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol

    J. Clin. Invest.

    (1989)
  • M Ratnam et al.

    Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA

    Biochemistry

    (1989)
  • F Shen et al.

    Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity

    Biochemistry

    (1994)
  • F Shen et al.

    Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity

    Biochemistry

    (1995)
  • H.L Monaco

    Crystal structure of chicken riboflavin-binding protein

    EMBO J.

    (1997)
  • G Wistow et al.

    Expressed sequence tag analysis of human retina for the NEIBank Project: retbindin, an abundant, novel retinal cDNA and alternative splicing of other retina-preferred gene transcripts

    Mol. Vis.

    (2002)
  • J Selhub et al.

    Renal folate absorption and the kidney folate binding protein: II. Microinfusion studies

    Am. J. Physiol.

    (1987)
  • J Selhub et al.

    Renal folate absorption and the kidney folate binding protein: I. Urinary clearance studies

    Am. J. Physiol.

    (1987)
  • M da Costa et al.

    Folate deficiency reduces the GPI-anchored folate-binding protein in rat renal tubules

    Am. J. Physiol. Cell. Physiol.

    (2000)
  • S.B Gates et al.

    Characterization of folate receptor from normal and neoplastic murine tissue: influence of dietary folate on folate receptor expression

    Clin. Cancer Res.

    (1996)
  • G.I Henderson et al.

    Maternal-to-fetal transfer of 5-methyltetrahydrofolate by the perfused human placental cotyledon: evidence for a concentrative role by placental folate receptors in fetal folate delivery

    J. Lab. Clin. Med.

    (1995)
  • J.A Piedrahita et al.

    Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development

    Nat. Genet.

    (1999)
  • M Ratnam et al.

    Receptor induction and targeted drug delivery: a new antileukaemia strategy

    Expert Opin. Biol. Ther.

    (2003)
  • C.M Ward

    Folate-targeted non-viral DNA vectors for cancer gene therapy

    Curr. Opin. Mol. Ther.

    (2000)
  • C.A Ladino et al.

    Folate-maytansinoids: target-selective drugs of low molecular weight

    Int. J. Cancer

    (1997)
  • C.P Leamon et al.

    Selective targeting of malignant cells with cytotoxin-folate conjugates

    J. Drug Target.

    (1994)
  • H Andersson et al.

    Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18

    Anticancer Res.

    (2000)
  • S.D Konda et al.

    Biodistribution of a 153 Gd-folate dendrimer, generation=4, in mice with folate-receptor positive and negative ovarian tumor xenografts

    Invest. Radiol.

    (2002)
  • C.P Leamon et al.

    Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical

    Bioconjug. Chem.

    (2002)
  • C.J Mathias et al.

    Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical

    Bioconjug. Chem.

    (2000)
  • Cited by (0)

    Supported by NIH RO1 grants CA 80183 and CA 70873 to M.R.

    View full text